CORC

在结果中检索

CORC

浏览/检索结果: 共106条，第1-10条 帮助

限定条件                    
已选(0)清除 条数/页：   排序方式：
Research on multi-AGV path planning in automated container terminal 会议论文
作者:  Yu, Meng;  He, Zhiling;  Li, Dawei;  Yin, Liang
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：35/0  |  提交时间：2019/12/05
Accurate Geometric Modeling and Scattering Characteristics Analysis of Complex Targets 会议论文
作者:  Bian, Zhi-Dan;  Zhu, Ling-Kun;  Deng, Gu-Ying;  Lei-Zhang;  He, Si-Yuan
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
Mobile data sharing with multiple user collaboration in mobile crowdsensing (Short Paper) 会议论文
作者:  Yang, Changjia;  Li, Peng;  Zhang, Tao;  Jin, Yu;  He, Heng
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
FDG/PET-CT-Based Supraclavicular Lymph Nodes Atlas in Breast Cancer Patients from Two Central China Cancer Centers 会议论文
作者:  Zeng, Y.;  Ke, Y.;  Li, L.;  Chen, M.;  Ding, Y. P.
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
FDG/PET-CT-Based Supraclavicular Lymph Nodes Atlas in Breast Cancer Patients from Two Central China Cancer Centers 会议论文
作者:  Zeng, Y.;  Ke, Y.;  Li, L.;  Chen, M.;  Ding, Y. P.
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
Exploiting sociality for collaborative message dissemination in VANETs 会议论文
作者:  Huang, Weiyi;  Li, Peng;  Zhang, Tao;  Jin, Yu;  He, Heng
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace